Search

Search Bar
28/08/2021 Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review
Palacio-Vieira, J, Reyes-Uruena, JM, Imaz, A, Bruguera, A, Force, L, Llaveria, AO, Llibre, JM, Vilaro, I, Borras, FH, Falco, V, Riera, M, Domingo, P, de Lazzari, E, Miro, JM, Casabona, J, Gurgui M., Hernandez, J.. Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review. BMC PUBLIC HEALTH. 2021; 21(1)DOI:10.1186/s12889-021-11613-y. PMID:34454444. IF:4.135(Q2/4D).
01/08/2021 Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial
Rojas, J, de Lazzari, E, Negredo, E, Domingo, P, Tiraboschi, J, Ribera, E, Abdulghani, N, Puig, J, Mateo, MG, Podzamczer, D, Gutierrez, MM, Paredes, R, Clotet, B, Gatell, JM, Blanco, JL, Martinez, E, DOLAM Study Grp. Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial. Lancet HIV. 2021; 8(8)DOI:10.1016/S2352-3018(21)00100-4. PMID:34358497. IF:16.070(Q1/1D).
01/07/2021 Not all COVID-19 pandemic waves are alike
Domingo, P, Pomar, V, Mur, I, Castellvi, I, Corominas, H, de Benito, N. Not all COVID-19 pandemic waves are alike. CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(7)DOI:10.1016/j.cmi.2021.04.005. PMID:33887469. IF:13.310(Q1/1D).
31/12/2022 Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy
Domingo, P, Giralt, M, Gavalda-Navarro, A, Blasco-Roset, A, Delgado-Angles, A, Gallego-Escuredo, JM, Gutierrez, MD, Mateo, MG, Cereijo, R, Domingo, JC, Villarroya, F, Villarroya, J. Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy. Adipocyte. 2022; 11(1)DOI:10.1080/21623945.2022.2042962. PMID:35300561. IF:3.300(Q3/6D).
19/10/2022 The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)
Llaurado, G, Vlacho, B, Wargny, M, Ruan, Y, Franch-Nadal, J, Domingo, P, Gourdy, P, Saulnier, PJ, Hadjadj, S, Wild, SH, Rea, R, Cariou, B, Khunti, K, Mauricio, D. The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19). Cardiovascular Diabetology. 2022; 21(1)DOI:10.1186/s12933-022-01657-8. PMID:36261811. IF:9.300(Q1/1D).
14/09/2022 Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254
Spinner, CD, Felizarta, F, Rizzardini, G, Philibert, P, Mitha, E, Domingo, P, Stephan, CJ, DeGrosky, M, Bainbridge, V, Zhan, J, Dumitrescu, TP, Jeffrey, JL, Xu, JF, Halliday, F, Gan, JJ, Johnson, M, Gartland, M, Joshi, SR, Lataillade, M. Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254. CLINICAL INFECTIOUS DISEASES. 2022; 75(5)DOI:10.1093/cid/ciab1065. PMID:34996113. IF:11.800(Q1/1D).